Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache Disorders Grant
Funding Amount
Up to US $250,000
Deadline
Deadline not published
Grant Type
Foundation
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Other requirements
- You must be a member of this organization to apply for this award - become a member.
- The applicant must be a member of the American Headache Society
Overview
Pfizer, in collaboration with the American Headache Society, invites innovative proposals for quality improvement initiatives targeting gaps in headache medicine. The focus is on enhancing patient outcomes through effective diagnosis, treatment, and management strategies, as well as education in medical training. This grant aims to develop widely usable tools and information that promote patient-centered care and equity for those affected by migraine and headache disorders.
Note: Only accepted LOIs will be invited to submit full proposals. LOI Submission Deadline is indicated above as the due date for Letter of Inquiry.
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Headache & Migraine Competitive Grant Program: Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache Disorders
Overview
Pfizer and the American Headache Society are collaborating to offer a new grant opportunity seeking proposals for quality improvement initiatives that will address quality gaps in headache medicine, with a goal of producing information or tools that can be widely used in the field and lead to measurable improvements in healthcare services for individuals with headache. Projects should also contribute to the core goal of the American Headache Society (AHS) – improving the lives of people impacted by migraine and other headache disorders.
Projects should focus on safety, clinical effectiveness, rapidity of diagnosis/proper treatment, efficiency, patient centered care, and/or equity. The program is not intended to support laboratory science or clinical trials. Project proposals should align with the following core focus areas:
Diagnosis, treatment and management in primary care and non-headache specialty settings for adult populationsCollect and analyze patient experience data across multiple sites or a broad populationnnovative solutions for standardized delivery of headache care and exploration of AI applications in primary care and non-headache specialty settingsEducation specific to headache disorders in medical/allied health schools and residency training
Eligibility
You must be a member of this organization to apply for this award - become a member. The applicant must be a member of the American Headache Society
What The Pfizer Foundation Inc actually gave
Source: IRS Form 990-PF, 2024
- Grants in 2024
- 9,306
- Total given
- $23.24M
Focus Areas & Funding Uses
Fields of Work
- Healthcare
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Bronchoscopy Research Grant
Intuitive Foundation
Amount
Up to US $75,000
Deadline
January 4, 2027
Listed date — confirm with the funder
The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) - Clinical Research Centers (U01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$3,000,000 total
Deadline
March 5, 2027
The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) Scientific Data Research Center (U24 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$1,500,000 total
Deadline
March 5, 2027
Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma Grant
The Pfizer Foundation Inc
Amount
US $50,000 - US $200,000
Deadline
Deadline not published
Pfizer Clostridioides difficile (C. difficile) Research Collaboration Grant
The Pfizer Foundation Inc
Amount
Up to US $500,000
Deadline
Deadline not published
Quality Improvement in Molecular Testing Pathways for Metastatic Colorectal Cancer (mCRC) Grant
The Pfizer Foundation Inc
Amount
US $150,000 - US $250,000
Deadline
Deadline not published
Ready to apply for Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache Disorders Grant?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache Disorders Grant. Now let's win it.